Core Insights - Flowserve reported quarterly earnings of $0.9 per share, exceeding the Zacks Consensus Estimate of $0.8 per share, and up from $0.62 per share a year ago [1][2] - The earnings surprise was +12.50%, with a previous quarter surprise of +16.67% [2] - Revenue for the quarter was $1.17 billion, missing the Zacks Consensus Estimate by 2.8%, but up from $1.13 billion year-over-year [3] Earnings Performance - Flowserve has surpassed consensus EPS estimates three times over the last four quarters [2] - The company has only topped consensus revenue estimates once in the last four quarters [3] Stock Performance - Flowserve shares have declined approximately 8.2% year-to-date, contrasting with the S&P 500's gain of 16.9% [4] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the market [7] Future Outlook - Current consensus EPS estimate for the upcoming quarter is $0.93 on revenues of $1.27 billion, and for the current fiscal year, it is $3.37 on revenues of $4.81 billion [8] - The industry outlook is critical, with the Manufacturing - General Industrial sector ranking in the bottom 38% of Zacks industries [9] Related Industry Insights - Xometry, another company in the same industry, is expected to report earnings of $0.11 per share, reflecting a year-over-year increase of +450% [10] - Xometry's anticipated revenues are $168.23 million, representing an 18.7% increase from the previous year [11]

Core Insights - Cheesecake Factory reported quarterly earnings of $0.68 per share, exceeding the Zacks Consensus Estimate of $0.60 per share, and showing an increase from $0.58 per share a year ago, resulting in an earnings surprise of +13.33% [1] - The company generated revenues of $907.23 million for the quarter ended September 2025, which was slightly below the Zacks Consensus Estimate by 0.63%, but an increase from $865.47 million year-over-year [2] - Cheesecake Factory's stock has increased approximately 17.9% year-to-date, outperforming the S&P 500's gain of 16.9% [3] Earnings Outlook - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The current consensus EPS estimate for the next quarter is $1.11 on revenues of $969.08 million, and for the current fiscal year, it is $3.77 on revenues of $3.76 billion [7] Industry Context - The Retail - Restaurants industry, to which Cheesecake Factory belongs, is currently ranked in the bottom 11% of over 250 Zacks industries, indicating potential challenges ahead [8] - The performance of Cheesecake Factory's stock may be influenced by the overall outlook for the industry, as historical data shows that the top 50% of Zacks-ranked industries outperform the bottom 50% by more than 2 to 1 [8] Estimate Revisions - Prior to the earnings release, the estimate revisions trend for Cheesecake Factory was mixed, resulting in a Zacks Rank 3 (Hold) for the stock, suggesting it is expected to perform in line with the market in the near future [6] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]

分组1 - Archrock Inc. reported quarterly earnings of $0.42 per share, exceeding the Zacks Consensus Estimate of $0.41 per share, and showing an increase from $0.28 per share a year ago, resulting in an earnings surprise of +2.44% [1] - The company achieved revenues of $382.43 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 1.34% and increasing from $292.16 million year-over-year [2] - Archrock has consistently surpassed consensus EPS estimates over the last four quarters, indicating strong performance [2] 分组2 - The stock has underperformed the market with a gain of about 2.7% since the beginning of the year, compared to the S&P 500's gain of 16.9% [3] - The current consensus EPS estimate for the upcoming quarter is $0.41 on revenues of $381.63 million, and for the current fiscal year, it is $1.57 on revenues of $1.49 billion [7] - The Zacks Industry Rank places Oil and Gas - Field Services in the bottom 36% of over 250 Zacks industries, suggesting potential challenges for stock performance [8]

Core Viewpoint - PPG Industries reported quarterly earnings of $2.13 per share, exceeding the Zacks Consensus Estimate of $2.09 per share, with revenues of $4.08 billion, surpassing estimates by 1.14% [1][2] Financial Performance - The company achieved an earnings surprise of +1.91% for the quarter, maintaining the same earnings per share as the previous year [1] - PPG Industries' revenues decreased from $4.58 billion a year ago to $4.08 billion this quarter [2] - Over the last four quarters, the company has surpassed consensus EPS estimates two times and revenue estimates three times [2] Stock Performance - PPG Industries shares have declined approximately 11.7% since the beginning of the year, contrasting with the S&P 500's gain of 16.9% [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating expectations of underperformance in the near future [6] Future Outlook - The current consensus EPS estimate for the upcoming quarter is $1.76 on revenues of $3.81 billion, and for the current fiscal year, it is $7.81 on revenues of $15.73 billion [7] - The outlook for the Chemical - Specialty industry, where PPG operates, is currently in the bottom 35% of Zacks industries, which may negatively impact stock performance [8]

Core Insights - Neurocrine Biosciences reported quarterly earnings of $2.04 per share, exceeding the Zacks Consensus Estimate of $1.58 per share, and showing an increase from $1.24 per share a year ago, resulting in an earnings surprise of +29.11% [1] - The company achieved revenues of $794.9 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 6.73% and up from $622.1 million year-over-year [2] - Neurocrine shares have increased approximately 9.1% year-to-date, while the S&P 500 has gained 16.9% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $1.71 on revenues of $785.17 million, and for the current fiscal year, it is $4.49 on revenues of $2.79 billion [7] - The estimate revisions trend for Neurocrine was mixed prior to the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [6] Industry Context - The Medical - Drugs industry, to which Neurocrine belongs, is currently ranked in the top 34% of over 250 Zacks industries, suggesting that stocks in the top 50% outperform those in the bottom 50% by more than 2 to 1 [8] - Amneal Pharmaceuticals, another company in the same industry, is expected to report quarterly earnings of $0.13 per share, reflecting a year-over-year decline of -18.8%, with revenues projected at $773.6 million, up 10.1% from the previous year [9][10]

Core Insights - NeoGenomics reported quarterly earnings of $0.03 per share, exceeding the Zacks Consensus Estimate of $0.02 per share, but down from $0.05 per share a year ago, resulting in an earnings surprise of +50.00% [1] - The company generated revenues of $187.8 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 2.27% and increasing from $167.82 million year-over-year [2] - NeoGenomics shares have declined approximately 38.4% year-to-date, contrasting with the S&P 500's gain of 16.9% [3] Earnings Outlook - The future performance of NeoGenomics stock will largely depend on management's commentary during the earnings call and the company's earnings outlook [4] - The current consensus EPS estimate for the upcoming quarter is $0.04 on revenues of $189.51 million, and for the current fiscal year, it is $0.09 on revenues of $722.29 million [7] Industry Context - The Medical - Biomedical and Genetics industry, to which NeoGenomics belongs, is currently ranked in the top 37% of over 250 Zacks industries, indicating a favorable outlook compared to lower-ranked industries [8] - The correlation between near-term stock movements and earnings estimate revisions suggests that tracking these revisions can provide insights into stock performance [5]

Paypal (PYPL) came out with quarterly earnings of $1.34 per share, beating the Zacks Consensus Estimate of $1.19 per share. This compares to earnings of $1.2 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +12.61%. A quarter ago, it was expected that this technology platform and digital payments company would post earnings of $1.3 per share when it actually produced earnings of $1.4, delivering a surprise of +7.69%.Over the la ...

Core Insights - Xylem reported quarterly earnings of $1.37 per share, exceeding the Zacks Consensus Estimate of $1.24 per share, and showing an increase from $1.11 per share a year ago, resulting in an earnings surprise of +10.48% [1] - The company achieved revenues of $2.27 billion for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 1.98% and up from $2.1 billion year-over-year [2] - Xylem's stock has increased by approximately 28.8% since the beginning of the year, outperforming the S&P 500's gain of 16.9% [3] Earnings Outlook - The future performance of Xylem's stock will largely depend on management's commentary during the earnings call and the company's earnings outlook [4] - Current consensus EPS estimate for the upcoming quarter is $1.31 on revenues of $2.37 billion, and for the current fiscal year, it is $4.84 on revenues of $8.96 billion [7] Industry Context - The Waste Removal Services industry, to which Xylem belongs, is currently ranked in the bottom 35% of over 250 Zacks industries, indicating potential challenges ahead [8] - Another company in the same industry, Select Water Solutions, is expected to report a significant decline in earnings, with a projected EPS of $0.05, reflecting a year-over-year change of -66.7% [9]

Core Insights - Tenet Healthcare (THC) reported quarterly earnings of $3.7 per share, exceeding the Zacks Consensus Estimate of $3.33 per share, and up from $2.93 per share a year ago, representing an earnings surprise of +11.11% [1] - The company achieved revenues of $5.29 billion for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 1.02% and showing an increase from $5.12 billion year-over-year [2] - Tenet shares have increased approximately 71.3% year-to-date, significantly outperforming the S&P 500's gain of 16.9% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $4.13 on revenues of $5.39 billion, and for the current fiscal year, it is $15.82 on revenues of $21.16 billion [7] - The estimate revisions trend for Tenet was mixed prior to the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [6] Industry Context - The Medical - Hospital industry, to which Tenet belongs, is currently ranked in the top 16% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]

Core Insights - Zebra Technologies reported quarterly earnings of $3.88 per share, exceeding the Zacks Consensus Estimate of $3.75 per share, and up from $3.49 per share a year ago [1] - The company achieved an earnings surprise of +3.47% for the quarter, having surpassed consensus EPS estimates in all four of the last quarters [2] - Zebra's revenues for the quarter reached $1.32 billion, surpassing the Zacks Consensus Estimate by 0.71% and increasing from $1.26 billion year-over-year [3] Earnings Performance - The earnings surprise of +3.47% indicates strong performance relative to expectations, with a previous quarter surprise of +9.06% [2] - Over the last four quarters, Zebra has consistently exceeded consensus revenue estimates [3] Stock Performance and Outlook - Zebra shares have declined approximately 19.6% year-to-date, contrasting with the S&P 500's gain of 16.9% [4] - The company's future stock performance will largely depend on management's commentary during the earnings call and the outlook for earnings revisions [5][6] Earnings Estimates - Current consensus EPS estimate for the upcoming quarter is $4.23, with expected revenues of $1.38 billion, and for the current fiscal year, the estimate is $15.67 on revenues of $5.29 billion [8] - The estimate revisions trend for Zebra was mixed prior to the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [7] Industry Context - Zebra operates within the Manufacturing - Thermal Products industry, which is currently ranked in the top 38% of over 250 Zacks industries, suggesting a favorable industry outlook [9]